Polymeric Biomaterials Market, by Application (Neurology, Cardiology, Orthopedics, Ophthalmology, Wound Care, Other Applications): Global Opportunity Analysis and Industry Forecast, 2020-2027

The global polymeric biomaterials market is estimated to surpass $54.1 million by 2027, exhibiting a CAGR of 8.8% from 2020 to 2027.

The report offers a thorough analysis of global polymeric biomaterials market with detailed study of various aspects of the market such as market dynamics, vital segments, major geographies, key players, and competitive landscape.

The report provides a clear picture of the current market situation and future trends of the global polymeric biomaterials market based on impact of various market dynamics and vital forces influencing the market. The drivers and opportunities in the market contributing to the market growth are acknowledged in the market dynamics. Besides, challenges and restraints that hold potential to hamper the market growth are also premeditated in the global polymeric biomaterials market. Porter’s five forces analysis is delivered through the report which precisely highlights the effects of key forces on the global polymeric biomaterials market.

The report offers market size and estimations analyzing global polymeric biomaterials market through various segments. In addition, the report includes geographical market analysis of these segments. Each segment entailed in the report is studied at regional and country level as well to provide complete coverage of global polymeric biomaterials market. The report categorizes the global polymeric biomaterials market into four major geographies including North America, Europe, Asia-Pacific, and LAMEA. These geographies are further sub-categorized into countries to cover polymeric biomaterials market scenario across in respective regions.

Furthermore, the report covers competitive scenario of the global polymeric biomaterials market. The key players operating in the global polymeric biomaterials market are studied in the report to understand their current market position and competitive strengths in the industry. The report profiles 10 key companies. Moreover, the company profiles include various data-points such as company overview, company executives, recent financials of the company, major growth strategies espoused by company, new initiatives and advancements by company to sustain and mend their position in the global polymeric biomaterials market, and others.

Research Methodology

We offer our clients comprehensive research and analysis based on an extensive variety of factual inputs, which mostly include industry participants’ interviews, reliable statistics, and regional acumen. The in-house market experts play an impactful role in designing analytic models and tools, personalized to the requirements of a market segment. These analytical models and tools sterilize the data and statistics and enrich the accuracy of our advice and recommendations.

For accomplishment of this research report, long hours of discussions and interviews have been conducted, with an extensive range of stakeholders that includes upstream and downstream participants. A number of product type literatures, annual reports, industry releases, and other related documents of key industry contributors have been reviewed, for better understanding of the market. We have executed a mix of primary and secondary research for the market estimates and forecasts. Secondary research formulae the initial phase of our detailed study, where we conduct wide-range data mining, referring to certified data sources such as technical journals, medical journals, independent studies, trade association’s releases, materials published by government and regulatory authorities.

KEY MARKET BENEFITS

• The report is a compilation of detailed information, inputs from industry participants and industry experts across the value chain, and quantitative and qualitative assessment by industry analysts.

• This report provides in-depth analysis of current market trends, governing factors, macro-economic indicators from 2019 to 2027 to identify & understand the prevailing opportunities and the strategic assessment of the growth of the global polymeric biomaterials market.

• The report maps the qualitative sway of various industry factors on market segments as well as geographies.

• The market estimations and size provided in the report are based on a comprehensive analysis of recent & futuristic key developments in the polymeric biomaterials market.

• The growth and development strategies adopted by the prominent industry players are enlisted in the report to understand the competitive scenario of the polymeric biomaterials market.

KEY MARKET SEGMENTS

The global polymeric biomaterials market is segmented on the basis of following:

• Application: Neurology, Cardiology, Orthopedics, Ophthalmology, Wound Care, Other Applications

• Region: North America, Europe, Asia Pacific, and LAMEA.

This segment is further sub-segmented into the following regions:

• North America
  • U.S.
  • Canada
  • Mexico

• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

• LAMEA
  • Brazil
  • Argentina
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of LAMEA

KEY MARKET PLAYERS

The global polymeric biomaterials market is consolidated with the presence of large number of key players. These players focus upon innovation and expansion of product portfolios to acquire a competitive edge in the market space. The report summarizes various aspects of all these key players including financial performance, product portfolio, recent strategic moves & developments, and SWOT analysis.

Players in global polymeric biomaterials market include:

1. Bayer AG

2. BASF SE

3. DSM Biomedical, Inc.

4. Evonik Industries AG

5. Purac Biomaterials

6. Ticona GmbH

7. Invibo Ltd

8. Covalon Technologies

9. Osteotech, Inc.

10. Starch Medical, Inc.

• 1. RESEARCH METHODOLOGY

  • 1.1. Desk Research

  • 1.2. Real time insights and validation

  • 1.3. Forecast model

  • 1.4. Assumptions and forecast parameters

  • 1.5. Market size estimation

    • 1.5.1. Top-down approach

    • 1.5.2. Bottom-up approach

• 2. REPORT SCOPE

  • 2.1. Market definition

  • 2.2. Key objectives of the study

  • 2.3. Report overview

  • 2.4. Market segmentation

  • 2.5. Overview of the impact of COVID-19 on Global Polymeric Biomaterials Market

• 3. EXECUTIVE SUMMARY

• 4. MARKET OVERVIEW

  • 4.1. Introduction

  • 4.2. Growth impact forces

    • 4.2.1. Drivers

    • 4.2.2. Restraints

    • 4.2.3. Opportunities

  • 4.3. Market value chain analysis

    • 4.3.1. List of raw material suppliers

    • 4.3.2. List of manufacturers

    • 4.3.3. List of distributors

  • 4.4. Innovation & sustainability matrices

    • 4.4.1. Technology matrix

    • 4.4.2. Regulatory matrix

  • 4.5. Porter’s five forces analysis

    • 4.5.1. Bargaining power of suppliers

    • 4.5.2. Bargaining power of consumers

    • 4.5.3. Threat of substitutes

    • 4.5.4. Threat of new entrants

    • 4.5.5. Competitive rivalry intensity

  • 4.6. PESTLE analysis

    • 4.6.1. Political

    • 4.6.2. Economical

    • 4.6.3. Social

    • 4.6.4. Technological

    • 4.6.5. Environmental

  • 4.7. Impact of COVID-19 on Polymeric Biomaterials Market

    • 4.7.1. Pre-covid market scenario

    • 4.7.2. Post-covid market scenario

• 5. Polymeric Biomaterials Market, By End Use

  • 5.1. Overview

  • 5.2 Neurology

    • 5.2.1 Definition, key trends, growth factors, and opportunities

    • 5.2.2 Market size analysis, by region, 2020-2027

    • 5.2.3 Market share analysis, by country, 2020-2027

  • 5.3 Cardiology

    • 5.3.1 Definition, key trends, growth factors, and opportunities

    • 5.3.2 Market size analysis, by region, 2020-2027

    • 5.3.3 Market share analysis, by country, 2020-2027

  • 5.4 Orthopedics

    • 5.4.1 Definition, key trends, growth factors, and opportunities

    • 5.4.2 Market size analysis, by region, 2020-2027

    • 5.4.3 Market share analysis, by country, 2020-2027

  • 5.5 Ophthalmology

    • 5.5.1 Definition, key trends, growth factors, and opportunities

    • 5.5.2 Market size analysis, by region, 2020-2027

    • 5.5.3 Market share analysis, by country, 2020-2027

  • 5.6 Wound Care

    • 5.6.1 Definition, key trends, growth factors, and opportunities

    • 5.6.2 Market size analysis, by region, 2020-2027

    • 5.6.3 Market share analysis, by country, 2020-2027

  • 5.7 Other Applications

    • 5.7.1 Definition, key trends, growth factors, and opportunities

    • 5.7.2 Market size analysis, by region, 2020-2027

    • 5.7.3 Market share analysis, by country, 2020-2027

  • 5.8 Research Dive Exclusive Insights

    • 5.8.1 Market attractiveness

    • 5.8.2 Competition heatmap

• 6. Polymeric Biomaterials Market, By Region

  • 6.1 North America

    • 6.1.1 U.S

      • 6.1.1.1 Market size analysis, By End Use, 2020-2027

    • 6.1.2 Canada

      • 6.1.2.1 Market size analysis, By End Use, 2020-2027

    • 6.1.3 Mexico

      • 6.1.3.1 Market size analysis, By End Use, 2020-2027

    • 6.1.4 Research Dive Exclusive Insights

      • 6.1.4.1 Market attractiveness

      • 6.1.4.2 Competition heatmap

  • 6.2 Europe

    • 6.2.1 Germany

      • 6.2.1.1 Market size analysis, By End Use, 2020-2027

    • 6.2.2 UK

      • 6.2.2.1 Market size analysis, By End Use, 2020-2027

    • 6.2.3 France

      • 6.2.3.1 Market size analysis, By End Use, 2020-2027

    • 6.2.4 Spain

      • 6.2.4.1 Market size analysis, By End Use, 2020-2027

    • 6.2.5 Italy

      • 6.2.5.1 Market size analysis, By End Use, 2020-2027

    • 6.2.6 Rest of Europe

      • 6.2.6.1 Market size analysis, By End Use, 2020-2027

    • 6.2.7 Research Dive Exclusive Insights

      • 6.2.7.1 Market attractiveness

      • 6.2.7.2 Competition heatmap

  • 6.3 Asia-Pacific

    • 6.3.1 China

      • 6.3.1.1 Market size analysis, By End Use, 2020-2027

    • 6.3.2 Japan

      • 6.3.2.1 Market size analysis, By End Use, 2020-2027

    • 6.3.3 India

      • 6.3.3.1 Market size analysis, By End Use, 2020-2027

    • 6.3.4 Australia

      • 6.3.4.1 Market size analysis, By End Use, 2020-2027

    • 6.3.5 South Korea

      • 6.3.5.1 Market size analysis, By End Use, 2020-2027

    • 6.3.6 Rest of Asia-Pacific

      • 6.3.6.1 Market size analysis, By End Use, 2020-2027

    • 6.3.7 Research Dive Exclusive Insights

      • 6.3.7.1 Market attractiveness

      • 6.3.7.2 Competition heatmap

  • 6.4 LAMEA

    • 6.4.1 Brazil

      • 6.4.1.1 Market size analysis, By End Use, 2020-2027

    • 6.4.2 Saudi Arabia

      • 6.4.2.1 Market size analysis, By End Use, 2020-2027

    • 6.4.3 UAE

      • 6.4.3.1 Market size analysis, By End Use, 2020-2027

    • 6.4.4 South Africa

      • 6.4.4.1 Market size analysis, By End Use, 2020-2027

    • 6.4.5 Rest of LAMEA

      • 6.4.5.1 Market size analysis, By End Use, 2020-2027

    • 6.4.6 Research Dive Exclusive Insights

      • 6.4.6.1 Market attractiveness

      • 6.4.6.2 Competition heatmap

• 7. Competitive Landscape

  • 7.1 Top winning strategies, 2020-2027

    • 7.1.1 By strategy

    • 7.1.2 By year

  • 7.2 Strategic overview

  • 7.3 Market share analysis, 2020-2027

• 8. Company Profiles

  • 8.1 Bayer AG

    • 8.1.1 Overview

    • 8.1.2 Business segments

    • 8.1.3 Product portfolio

    • 8.1.4 Financial performance

    • 8.1.5 Recent developments

    • 8.1.6 SWOT analysis

  • 8.2 BASF SE

    • 8.2.1 Overview

    • 8.2.2 Business segments

    • 8.2.3 Product portfolio

    • 8.2.4 Financial performance

    • 8.2.5 Recent developments

    • 8.2.6 SWOT analysis

  • 8.3 DSM Biomedical, Inc.

    • 8.3.1 Overview

    • 8.3.2 Business segments

    • 8.3.3 Product portfolio

    • 8.3.4 Financial performance

    • 8.3.5 Recent developments

    • 8.3.6 SWOT analysis

  • 8.4 Evonik Industries AG

    • 8.4.1 Overview

    • 8.4.2 Business segments

    • 8.4.3 Product portfolio

    • 8.4.4 Financial performance

    • 8.4.5 Recent developments

    • 8.4.6 SWOT analysis

  • 8.5 Purac Biomaterials

    • 8.5.1 Overview

    • 8.5.2 Business segments

    • 8.5.3 Product portfolio

    • 8.5.4 Financial performance

    • 8.5.5 Recent developments

    • 8.5.6 SWOT analysis

  • 8.6 Ticona GmbH

    • 8.6.1 Overview

    • 8.6.2 Business segments

    • 8.6.3 Product portfolio

    • 8.6.4 Financial performance

    • 8.6.5 Recent developments

    • 8.6.6 SWOT analysis

  • 8.7 Invibo Ltd

    • 8.7.1 Overview

    • 8.7.2 Business segments

    • 8.7.3 Product portfolio

    • 8.7.4 Financial performance

    • 8.7.5 Recent developments

    • 8.7.6 SWOT analysis

  • 8.8 Covalon Technologies

    • 8.8.1 Overview

    • 8.8.2 Business segments

    • 8.8.3 Product portfolio

    • 8.8.4 Financial performance

    • 8.8.5 Recent developments

    • 8.8.6 SWOT analysis

  • 8.9 Osteotech, Inc.

    • 8.9.1 Overview

    • 8.9.2 Business segments

    • 8.9.3 Product portfolio

    • 8.9.4 Financial performance

    • 8.9.5 Recent developments

    • 8.9.6 SWOT analysis

  • 8.10 Starch Medical, Inc.

    • 8.10.1 Overview

    • 8.10.2 Business segments

    • 8.10.3 Product portfolio

    • 8.10.4 Financial performance

    • 8.10.5 Recent developments

    • 8.10.6 SWOT analysis

* Taxes/Fees, If applicable will be added during checkout. All prices in USD.